MarginsXMarginsX
Home › Markets › Finance › DMII

Drugs Made In America Acquisition II Corp. (DMII)

DMII trades on Nasdaq in Finance, Blank Checks. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$10.24
0.00% on the day
Market cap
Market cap not reported by the Nasdaq screener
Revenue
Recent IPO: no annual report filed yet
Net income
Recent IPO: no annual report filed yet

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerDMII on Nasdaq
SectorFinance
IndustryBlank Checks
CountryUnited States
IPO year2025
SEC CIK0002040475
SEC industry codeBlank Checks

Financials

Recent IPO: no annual report filed yet.

Warning signs

Cash runway
1.6 months
$175K cash at June 30, 2026
Share count, 1 year
No year-earlier count
Going-concern doubt
Yes
10-Q filed August 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board's Accounting Standards Update ( ASU ) 2014-15, Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern, management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date tha"
10-Q 2026-08-14
Cash and burn$175K cash; operating cash flow -$320K a quarter.Report 2026-06-30
Shares outstanding63,700,000 (2026-08-14).Cover page 2026-08-14
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorMaloneBailey, LLP, Houston, Texas, United StatesPCAOB Form AP 2026-04-20
Late filings, 12 months2 NT noticesNT 10-K 2026-04-01
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed$4.4M-$173K$175K$900KNeeds four quarters10-Q 2026-08-14
Q1 2026
2026-03-31
Not filed$4.3M-$103K$348K$900KNeeds four quarters10-Q 2026-08-14
Q4 2025
2025-12-31
Not filed$4.3M-$315K$223No debt tagsNeeds four quarters10-K 2026-04-15
Q3 2025
2025-09-30
Not filed-$46K-$691K$315KNo debt tagsNeeds four quarters10-Q 2025-11-18
Q2 2025
2025-06-30
Not filed-$38K-$3K$4KNo debt tagsNeeds four quarters10-Q 2026-08-14
Q1 2025
2025-03-31
Not filed-$59K-$10K$7KNo debt tagsNeeds four quarters10-Q 2026-08-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS SUPPLEMENT
424B42025-09-25
Latest annual report
ANNUAL REPORT
10-K2026-04-15
Latest quarterly / interim
FORM 10-Q
10-Q2026-11-16
Latest current report
CURRENT REPORT
8-K2026-04-28

Source: SEC EDGAR submissions feed, 47 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.3%
1 month+0.5%
3 months+1.1%
Year to date+3.4%
1 yearNot enough price history
From 52-week high-0.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
DMIIRDrugs Made In America Acquisition II Corp. Right$0.0506
DMIIUDrugs Made In America Acquisition II Corp. Unit$10.25

Peers in Blank Checks

TickerCompanyPriceDayMarket cap
TACOBerto Acquisition Corp.$10.520.00%$383.4M
PREPrenetics Global Limited Class A Ordinary Share$15.48-6.24%$262.2M
ILLUIllumination Acquisition Corp I$10.000.00%$102.6M
OXSQOxford Square Capital Corp.$0.6201-14.47%$75.2M
INVInnventure Inc.$0.1185-12.80%$12.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier